Orion
Timo Lappalainen currently serves as a Senior Advisor at Orion Corporation since November 2022, after having held the position of President and CEO at the same company. Timo Lappalainen holds a Master's degree in Industrial Engineering from Helsinki University of Technology and has completed education at Harvard Business School.
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.